Bitsori M, Galanakis E. Pediatric urinary tract infections : diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10(10):1153–64. Paintsil E. Update on recent guidelines for the management of urinary tract infections in children : the shifting paradigm. Curr Opin. 2013;25(1):88–94. Sood A, Penna FJ, Eleswarapu S, Pucheril D, Weaver J, Wagner JC, et al. Incidence, admission rates and economic burden of pediatric emergency department visits for urinary tract infection: data from the nationwide emergency department sample, 2006 to 2011. J Pediatr Urol [Internet]. Elsevier Ltd; 2014;(2015). Available from: http://dx.doi.org/10.1016/j.jpurol.2014.10.005 Bitsori M, Maraki S, Kalmanti M. Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol. 2009;24:2381–6. Megged O. Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol. 2014 Fan N, Chen H, Chen C, Ou L, Lin T, Tsai M, et al. Rise of community-onset urinary tract infection caused by extended-spectrum b-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect [Internet]. Elsevier Taiwan LLC; 2013;1–7. Available from: http://dx.doi.org/10.1016/j.jmii.2013.05.006 Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int. 2012;54:858–62. Topaloglu R, Er I, Dogan BG. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol. 2010;25:919–25. Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing and Nonproducing Bacteria: A Comparative Study. J Pediatr [Internet]. Elsevier Ltd; 2013;163(5):1417–21. Available from: http://dx.doi.org/10.1016/j.jpeds.2013.06.078 Hoyos Á, Serna L, Ortiz G. Infección urinaria adquirida en la comunidad en pacientes pediátricos : clínica, factores de riesgo, etiología, resistencia a los antibióticos y respuesta a la terapia empírica Urinary tract infection acquired in the community in pediatric patients : Infectio. 2012;16(574):94–103. Coy A, Galindo A, Quijano C, Rodríguez Y. Caracterización de la población con diagnóstico de infección del tracto urinario en la Clínica Infantil Colsubsidio de enero a junio de 2013, Bogotá, Colombia. 2013. Srivastava RN, Vasudev AS. Urinary tract infections — current management. Apollo Med [Internet]. Indraprastha Medical Corporation Ltd.; 2011;8(4):270–5. Available from: http://dx.doi.org/10.1016/S0976-0016(11)60004-5 Morello W, Scola C La, Alberici I, Montini G. Acute pyelonephritis in children American Academy of Pediatrics. Pediatr Nephrol. 2016;31:1253–65. Jadresic LP. Diagnosis and management of urinary tract infections in children. Paediatr Child Health (Oxford). 2010;20(6):274–8. Flokas ME, Detsis M, Alevizakos M, Mylonakis E. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections : A systematic review and. J Infect [Internet]. Elsevier Ltd; 2016;1–11. Available from: http://dx.doi.org/10.1016/j.jinf.2016.07.014 Salas P, Barrera P, González C, Zambrano P, Salgado I, Quiroz L, et al. Actualización en el diagnóstico y manejo de la Infección Urinaria en pediatría . Rev Chil Pediatr. 2012;83(3):269–78. Becknell B, Schober M, Korbel L, Spencer JD, Becknell B, Schober M, et al. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev. 2016;7210(August):81–90. Nijman RJM, Radmayr C, Tekgu S. Urinary Tract Infections in Children: EAU / ESPU Guidelines. Eur Assoc Urol. 2015;67:546–58. NICE. Urinary tract infection in children diagnosis, treatment and long-term management. 2007. Bhat RG, Katy TA, Place FC. Pediatric Urinary Tract Infections. Emerg Med Clin NA [Internet]. Elsevier Inc; 2011;29(3):637–53. Available from: http://dx.doi.org/10.1016/j.emc.2011.04.004 Lukac PJ, Bonomo RA, Logan LK. Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children : Old Foe, Emerging Threat. Healthc Epidemiol. 2015;1–9. Aksu NU, Ekinci Z, Dündar D, Baydemir C. Childhood urinary tract infections caused by ESBL-producing bacteria: Risk factors and empiric therapy. Pediatr Int. 2016 Wiles TJ, Kulesus RR, Mulvey MA. Origins and Virulence Mechanisms of Uropathogenic Escherichia coli. Exp Mol Pathol. 2009;85(1):11–9. Rondon Mi, Rondon A. Infeccion del tracto urinario. 2011. Stephens GM, Woxland H. Evaluation and Management of Urinary Tract Infections in the School-Aged Child. Prim Care Clin Off Pract [Internet]. Elsevier Inc; 2015;42(1):33–41. Available from: http://dx.doi.org/10.1016/j.pop.2014.09.007 Paterson DL, Bonomo RA. Extended-Spectrum Beta-Lactamases: a Clinical Update. Clin Microbiol Rev. 2005;18(4):657–86. Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum b-lactamases ( ESBLs ) in the community. J Antimicrob Chemother. 2005;56:52–9. Jadresi L. Urinary tract infections in children. Paediatr Child Health (Oxford). 2013;24(7):289–92. Schmidt B, Copp HL. Work-up of Pediatric Urinary Tract Infection. Urol Clin NA [Internet]. Elsevier Inc; 2015;42(4):519–26. Available from: http://dx.doi.org/10.1016/j.ucl.2015.05.011 Melbourne TRCH. Urinary Tract Infection Guideline. 2014. Village EG. Urinary Tract Infection : Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months. Pediatrics. 2011;128(3):594–611. CLSI. Performance Standards for Antimicrobial Susceptibility Testing ; Twenty-Second Informational Supplement. 2012. Pujol M. El significado clínico de las betalactamasas de espectro extendido. Enferm Infecc Microbiol Clin. 2015;21(2):69–71. Dalgic N, Sancar M, Bayraktar B, Dincer E, Pelit S. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum b-lactamase-producing bacteria in children. Scand J Infect Dis. 2011;(January):339–43. Echeverri CV, Serna-higuita LM, Serrano AK, Ochoa-garcía C, Rosas LR, Bedoya M, et al. Profile resistance of pathogens causing urinary tract infection in the pediatric population, and antibiotic treatment response, at a University Hospital 2010-2011. Colomb Med. 2014;45(57):39–44. Pehlivanlar Önen S, Aslantaş Ö, Şebnem Yilmaz E, Kürekci C. Prevalence of β-Lactamase Producing Escherichia coli from Retail Meat in Turkey. J Food Sci. 2015;80(9):2023–9. Bhoomika, Shakya S, Patyal A, Gade NE. Occurrence and characteristics of extended-spectrum β-lactamases producing Escherichia coli in foods of animal origin and human clinical samples in Chhattisgarh, India. Vet World [Internet]. 2016;9(9):996–1000. Available from: http://www.veterinaryworld.org/Vol.9/September-2016/13.html Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis. 2011;17(7):1216–22. Hijazi SM, Fawzi MA, Ali FM, Abd El Galil KH. Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors. Ann Clin Microbiol Antimicrob [Internet]. BioMed Central; 2016;15(1):3. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4731960&tool=pmcentre z&rendertype=abstract Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario